Accessibility: Skip TopNav
Sabin Begins Marburg Vaccine Clinical Trial in U.S.
Sabin begins a multi-site Phase 2 clinical trial of its Marburg vaccine candidate in U.S.
Format
JPEG
Source
Sabin Vaccine Institute
Downloads
Original
Large
Medium
Small